Anti-ADAMTS-15 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the propeptide domain of human ADAMTS-15, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
Q8TE58
Size
100ug
Cat. #
RP1ADAMTS15

In stock

SKU
RP-ADAMTS15

Options

As low as: $130.00

Target Overview

ADAMTS-15 (a disintegrin and metalloproteinase with thrombospondin motifs 15, EC 3.4.24.-, UniProt Q8TE58) is a secreted metalloprotease localized to the extracellular matrix. The protein consists of 950 amino acids and belongs to the ADAMTS family of zinc-dependent proteases characterized by thrombospondin type 1 repeats. ADAMTS-15 exhibits proteolytic activity against the proteoglycan versican (VCAN), cleaving it at the Glu-1428-|-1429-Ala site. This cleavage occurs in the pericellular matrix surrounding myoblasts, facilitating cell-cell contact and fusion during skeletal muscle development and regeneration. Researchers study ADAMTS-15 in the context of extracellular matrix remodeling, myogenesis, and tissue repair, as well as in disease states where matrix turnover is dysregulated.

Background

ADAMTS-15 functions as an extracellular matrix remodeling enzyme with specificity for versican, a large chondroitin sulfate proteoglycan abundant in the pericellular space. By cleaving versican, ADAMTS-15 alters the composition of the matrix surrounding muscle precursor cells, enabling the close apposition necessary for myoblast fusion. This activity is critical during both embryonic muscle development and post-injury muscle regeneration in adults. Loss of ADAMTS-15 activity impairs myoblast fusion and delays muscle repair. Recent proteomic and genomic studies have identified ADAMTS-15 as a circulating protein mediator associated with smoking-related abdominal aortic aneurysm risk, suggesting a role in vascular extracellular matrix homeostasis (Yuan S et al, 2025). The protein has also been implicated in intestinal tissue protection against ischemia-reperfusion injury, where extracellular matrix remodeling is protective (Gökalp Özkorkmaz E et al, 2025). In rheumatoid arthritis, ADAMTS-15 expression is regulated by RNA m6A methylation pathways and contributes to synovial inflammation and aggression (Li R et al, 2024). The propeptide domain-targeted antibodies available from Triple Point Biologics (RP1ADAMTS15, RP2ADAMTS15) recognize human ADAMTS-15 with validated reactivity in Western blot, immunohistochemistry, and immunofluorescence. Cross-reactivity with mouse, rat, and other mammalian orthologs is predicted based on sequence conservation in the immunogen region.

References

  1. Yuan S et al (2025) Circulating Protein Mediators Linking Genetically Predicted Smoking to Abdominal Aortic Aneurysm: A Genomic-Proteomic Analysis. Arterioscler Thromb Vasc Biol. PubMed · DOI
  2. Gökalp Özkorkmaz E et al (2025) Honokiol remodeled the extracellular matrix and protected the intestinal tissue against ischemia-reperfusion injury in rats. Pol J Vet Sci. PubMed · DOI
  3. Li R et al (2024) FTO-mediated RNA m(6)A methylation regulates synovial aggression and inflammation in rheumatoid arthritis. Biochim Biophys Acta Mol Basis Dis. PubMed · DOI

Additional Specifications

Gene Symbol ADAMTS15
UniProt ID Q8TE58
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 18-212.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 218-427.
Alternate Names A disintegrin and metalloproteinase with thrombospondin motifs 15, ADAM-TS 15, ADAM-TS15, ADAMTS-15, EC 3.4.24.-

Frequently Asked Questions

What molecular weight band should I expect for ADAMTS-15 on Western blot?

ADAMTS-15 migrates at approximately 105-110 kDa on reducing SDS-PAGE, corresponding to the full-length 950-amino-acid protein. You may also observe a faster-migrating band around 85-90 kDa representing a processed form lacking the C-terminal ancillary domain. Because ADAMTS-15 is a secreted metalloprotease, band intensity will be strongest in conditioned media and extracellular matrix-enriched fractions. Detection in whole-cell lysates is typically weaker unless cells are actively secreting the enzyme during myogenesis or matrix remodeling.

What dilution should I start with for ADAMTS-15 Western blot?

We recommend starting at 1:1000 dilution for Western blot when using standard chemiluminescent detection. This dilution has been validated with human samples. Depending on ADAMTS-15 expression levels in your system, you may need to optimize between 1:500 and 1:2000. Secreted metalloproteases like ADAMTS-15 are often expressed at lower levels than cytosolic proteins, so concentrated conditioned media or matrix-enriched fractions typically yield stronger signals than whole-cell lysates. Include a titration series in your initial experiment to determine the optimal working concentration for your samples.

Will this antibody detect mouse or rat ADAMTS-15?

Cross-reactivity with mouse and rat ADAMTS-15 is predicted based on sequence homology but has not been experimentally validated. Human ADAMTS-15 shares approximately 85 percent sequence identity with mouse and rat orthologs in conserved domains. If you are working with rodent samples, we recommend testing the antibody at the same starting dilution (1:1000 for Western blot) and running a positive control with human recombinant ADAMTS-15 or lysate from a human cell line known to express the protease. Confirm specificity by siRNA knockdown or competition with immunizing peptide if available.

How should I prepare samples to detect ADAMTS-15 as a secreted protease?

Because ADAMTS-15 is secreted into the extracellular space, harvest conditioned serum-free media from cultured cells for 24-48 hours after reaching confluence. Concentrate media 10- to 20-fold using centrifugal filters (10 kDa cutoff) to enrich low-abundance secreted proteins. For tissue samples, consider extracting the extracellular matrix fraction with sequential salt and detergent buffers, as ADAMTS-15 associates with matrix components via its thrombospondin repeats. Include protease inhibitors that spare metalloproteases (avoid EDTA or chelators that strip zinc, which is required for structural integrity).

What are appropriate positive and negative controls for ADAMTS-15?

Use differentiating myoblast cultures (C2C12 or primary human myoblasts) as a positive control, since ADAMTS-15 is upregulated during myogenesis and facilitates cell fusion. Conditioned media collected during the differentiation phase typically shows robust expression. For tissue lysates, skeletal muscle undergoing regeneration or remodeling serves as a physiological positive control. Negative controls include non-muscle cell lines with minimal matrix remodeling activity or samples from cells transfected with ADAMTS-15-targeting siRNA. Recombinant human ADAMTS-15 protein provides an unambiguous molecular weight reference.

Does ADAMTS-15 have isoforms or splice variants I should know about?

The primary ADAMTS-15 transcript encodes the full-length 950-amino-acid protein. Minor splice variants have been reported in transcript databases, but functional characterization is limited and expression appears tissue-restricted. The most commonly observed variation on Western blot is proteolytic processing rather than alternative splicing. ADAMTS family members undergo post-translational cleavage that removes C-terminal ancillary domains, generating shorter active forms. If you observe multiple bands, consider that ADAMTS-15 may undergo autocatalytic or heterologous processing in the extracellular matrix, particularly in highly proteolytic environments.

Can I use this ADAMTS-15 antibody for immunohistochemistry or immunofluorescence?

This antibody has been validated for Western blot at 1:1000 dilution. Triple Point Biologics antibodies are routinely tested for IHC and immunofluorescence applications across the product line, but specific validation data for ADAMTS-15 in these formats should be confirmed with our technical support. For IHC, start at 1:100 to 1:200 dilution on formalin-fixed paraffin-embedded sections with heat-mediated antigen retrieval in citrate buffer. ADAMTS-15 localizes to the extracellular matrix and pericellular space, so expect diffuse extracellular staining in muscle and connective tissues rather than discrete intracellular compartments.

How should I store the ADAMTS-15 antibody and how long is it stable?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase background. The 100 µg pack size is sufficient for approximately 100 Western blots at 1:1000 dilution. Once thawed, an aliquot remains stable at 4°C for up to one month if supplemented with 0.02 percent sodium azide or another antimicrobial preservative. For long-term storage beyond two years, keep at -80°C. Do not store in frost-free freezers where temperature cycling can denature the antibody over time.

Western blot validation for RP-ADAMTS15 — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

ADAMTS-15: Propeptide domain — WB validation
WB · Panel 1 ADAMTS-15: Propeptide domain
ADAMTS-15: Metalloproteinase domain — WB validation
WB · Panel 2 ADAMTS-15: Metalloproteinase domain

Custom validation studies available on request — contact us.

Also known as:

  • A disintegrin and metalloproteinase with thrombospondin motifs 15
  • ADAM-TS 15
  • ADAM-TS15
  • ADAMTS-15
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →